Shaily Engineering Plastics Limited (SEPL), a leading manufacturer of precision plastic components, has been honored with the prestigious Best Exporter Award for Engineering Components of Plastics for FY2023-24 and FY2024-25 by The Plastics Export Promotion Council (Plexcouncil). This recognition underscores SEPL's dominance in the export of engineering plastic components among Indian manufacturers.

Award Details and Significance

The award certificate, presented by Plexcouncil, acknowledges SEPL's outstanding performance in exporting the highest number of engineering plastic components among Indian plastic manufacturers. This achievement highlights the company's commitment to quality and its strong position in the global market for precision plastic components.

Company's Response

In an official communication to the stock exchanges, SEPL expressed its honor in receiving this recognition. The company stated, "This remarkable success is a testament to Company's dedication, and strategic vision." This award not only validates SEPL's export-oriented business model but also reinforces its reputation as a key player in the global plastic engineering sector.

Impact on Business and Future Outlook

While specific financial implications of this recognition were not disclosed, such awards typically boost a company's credibility in international markets. For SEPL, this accolade could potentially lead to:

• Enhanced brand reputation in global markets
• Increased interest from international clients
• Potential for securing more export orders

Investor Perspective

For investors, this award serves as a positive indicator of SEPL's competitive edge in the international market. It demonstrates the company's ability to meet global quality standards and compete effectively against other manufacturers worldwide.

Conclusion

The Best Exporter Award is a significant milestone for Shaily Engineering Plastics Limited, reflecting its excellence in manufacturing and exporting engineering plastic components. As the company continues to strengthen its position in the global market, stakeholders will be keen to observe how this recognition translates into tangible business growth and market expansion opportunities in the coming years.

Shaily Engineering Plastics Limited (SEPL) has reported strong financial results for the second quarter of fiscal year 2026, demonstrating significant growth and expansion in its healthcare segment. The company's strategic focus on innovative drug delivery devices, particularly for GLP-1 medications, has driven its performance.

Financial Highlights

• Revenue grew by 34% year-on-year to INR 257.00 crores in Q2 FY26
• EBITDA doubled to INR 82.00 crores, with margins expanding by 1,030 basis points to 31.80%
• Profit After Tax (PAT) increased by 134% to INR 51.00 crores, with margins improving by 860 basis points to 20.00%

Segment Performance

The healthcare segment has shown remarkable growth, now contributing 38% to the overall revenue mix, doubling from the previous year.

Operational Highlights

• SEPL processed 6,652 tons of polymers in Q2 FY26, a 7.5% increase from Q2 FY25
• Machine utilization rate stands at 48% in both Q2 and H1 FY26
• Exports accounted for 68% of total revenue in Q2 FY26

Strategic Developments

Healthcare Segment Expansion

• Launched next-generation GLP-1 device, Shaily Axiom Max
• Signed four new projects across GLP-1 and other therapies
• Installed 19 new machines at manufacturing facilities

Capacity Expansion

• Increasing pen manufacturing capacity from 40 million to 80 million units by end of FY26
• Investing approximately INR 125.00 crores for capacity expansion in FY26

Consumer Segment

• Awarded 5 new projects from 3 marquee home furnishings customers

Industrial Segment

• Secured 1 new project from an automotive major

Consumer Electronics

• Expected to begin revenue generation in H2 FY26

Future Outlook

• Healthcare segment projected to grow at over 30-40% annually for the next few years
• Exploring opportunities in semiconductor business
• Potential for significant growth in Consumer Electronics segment by FY28

Amit Sanghvi, Managing Director of SEPL, commented on the results: "We have delivered strong revenue growth of 34% to INR 257.00 crores on a year-on-year basis, with EBITDA margins expanding by over 1,000 basis points to 31.80%. The growth is attributable to improved traction in our Healthcare segment, which showed a growth of 163% on a year-on-year basis to INR 98.60 crores."

The company's focus on innovation and expansion in the healthcare segment, particularly in drug delivery devices for GLP-1 medications, positions it well for continued growth. With ongoing capacity expansion and new product developments, Shaily Engineering Plastics appears poised for sustained performance in the coming years.

Investors should note that while the company's growth trajectory is impressive, market conditions and regulatory approvals, especially in international markets like Canada, may impact future performance. The management remains optimistic about the company's prospects across its diverse business segments.